Javascript must be enabled to continue!
Frequency of Thyroid Dysfunction in Patients with Non-Alcoholic Fatty Liver Disease
View through CrossRef
Objectives: To determine the frequency of thyroid dysfunction in patients with non-alcoholic fatty liver disease.
Methodology: This cross-sectional study was conducted at Rawal Institute of Health Sciences, Medicine Department, Islamabad, Pakistan, from August 2025 to February 2026. A total of 370 patients with non-alcoholic fatty liver disease were included; they were screened for the presence of any abnormality in the thyroid function (overt/subclinical hypothyroidism and hyperthyroidism). Thyroid dysfunction stratification was done based on confounding variables. Post-stratification analysis was done using the chi-square test.
Results: Median age was 54.00 (22.00) years. There were 197 (53.20%) male and 173 (46.80%) female patients. Median BMI was 30.46 (8.15) kg/m². History of smoking, diabetes, and hypertension was positive in 274 (74.10%), 186 (50.30%), and 187 (50.50%), respectively. Among non-alcoholic fatty liver disease patients, the frequency of thyroid dysfunction was 92 (24.90%). A total of 46 (12.43%) patients had subclinical hypothyroidism, 29 (7.84%) had overt hypothyroidism, and 17 (4.59%) had hyperthyroidism.
Conclusion: Thyroid dysfunction was found in 24.9% of the patients suffering from non-alcoholic fatty liver disease, with subclinical hypothyroidism being the most common type of dysfunction.
Keywords: Hyperthyroidism, Hypothyroidism, Non-Alcoholic Fatty Liver Disease,
Islamabad Medical and Dental College
Title: Frequency of Thyroid Dysfunction in Patients with Non-Alcoholic Fatty Liver Disease
Description:
Objectives: To determine the frequency of thyroid dysfunction in patients with non-alcoholic fatty liver disease.
Methodology: This cross-sectional study was conducted at Rawal Institute of Health Sciences, Medicine Department, Islamabad, Pakistan, from August 2025 to February 2026.
A total of 370 patients with non-alcoholic fatty liver disease were included; they were screened for the presence of any abnormality in the thyroid function (overt/subclinical hypothyroidism and hyperthyroidism).
Thyroid dysfunction stratification was done based on confounding variables.
Post-stratification analysis was done using the chi-square test.
Results: Median age was 54.
00 (22.
00) years.
There were 197 (53.
20%) male and 173 (46.
80%) female patients.
Median BMI was 30.
46 (8.
15) kg/m².
History of smoking, diabetes, and hypertension was positive in 274 (74.
10%), 186 (50.
30%), and 187 (50.
50%), respectively.
Among non-alcoholic fatty liver disease patients, the frequency of thyroid dysfunction was 92 (24.
90%).
A total of 46 (12.
43%) patients had subclinical hypothyroidism, 29 (7.
84%) had overt hypothyroidism, and 17 (4.
59%) had hyperthyroidism.
Conclusion: Thyroid dysfunction was found in 24.
9% of the patients suffering from non-alcoholic fatty liver disease, with subclinical hypothyroidism being the most common type of dysfunction.
Keywords: Hyperthyroidism, Hypothyroidism, Non-Alcoholic Fatty Liver Disease,.
Related Results
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Abstract
Introduction
Non-Hodgkin lymphoma (NHL) of the thyroid, a rare malignancy linked to autoimmune disorders, is poorly understood in terms of its pathogenesis and treatment o...
Clinicopathological Features of Indeterminate Thyroid Nodules: A Single-center Cross-sectional Study
Clinicopathological Features of Indeterminate Thyroid Nodules: A Single-center Cross-sectional Study
Abstract
Introduction
Due to indeterminate cytology, Bethesda III is the most controversial category within the Bethesda System for Reporting Thyroid Cytopathology. This study exam...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Hepatoprotective activity of Ammi majus on CCL4 Induced Albino Mice
Hepatoprotective activity of Ammi majus on CCL4 Induced Albino Mice
This study was amid to evaluate the possible protective effects of the water and alcoholic extract of Ammi majus seeds against liver damage induced in mice by CCL4. The plant was c...
Influence of non-alcoholic fatty liver disease on reproductive function in an experiment
Influence of non-alcoholic fatty liver disease on reproductive function in an experiment
BACKGROUND: Currently, the attention of specialists is drawn to the relationship between non-alcoholic fatty liver disease and the development of reproductive disorders in both men...
Grading of Fatty Liver Disease in Non-Obese Elderly Patients On Ultrasound
Grading of Fatty Liver Disease in Non-Obese Elderly Patients On Ultrasound
Background and Introduction: Non-alcoholic fatty liver disease (NAFLD) has been demonstrated that insulin resistance and metabolic syndrome are associated with non-alcoholic fatty ...
Diagnostic Value of Serum Procollagen Peptide Measurements in Alcoholic Liver Disease
Diagnostic Value of Serum Procollagen Peptide Measurements in Alcoholic Liver Disease
Procollagen type I carboxyterminal and type III aminoterminal peptide concentrations were measured in sera of 60 patients with alcoholic and 14 with nonalcoholic liver disease to s...
The Value of Quantitative Ultrasound Elastography in the Assessment of Non-Alcoholic Fatty Liver Disease in Children
The Value of Quantitative Ultrasound Elastography in the Assessment of Non-Alcoholic Fatty Liver Disease in Children
Objective:
This preliminary investigation aimed to assess the value of two elastography techniques, sound touch elastography (STE) and sound touch
quantification (STQ), in measurin...

